At the Medicines and Healthcare products Regulatory Agency (MHRA), an Expert Working Group (EWG) of the United Kingdom’s (UK’s) Commission on Human Medicines (CHM) met to begin reviewing the benefits and risks of opioid medicines, which includes dependence and addiction. Read more “Opioid Expert Working Group meets at MHRA”
Category: Press
Regulis Article Published in Regulatory Rapporteur
Amy Whyte and Kim Wharton wrote an article for the May edition of Regulatory Rapporteur titled ‘A Guide to Legal Status Switches in Europe’.